Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Oncogene|February 17, 2009
Matrix Metalloproteinase-9 gene induction by a truncated oncogenic NF-kappaB2 protein involves the recruitment of MLL1 and MLL2 H3K4 histone methyltransferase complexesI Robert, M Aussems, A Keutgens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2012
Diffuse large B-cell lymphoma of Waldeyer's ring has distinct clinicopathologic features: a GELA studyL de Leval, C Bonnet, C Copie-Bergman, et al.
Leukemia|June 4, 2010
Differential expression of NF-kappaB target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanismR A Hamoudi, A Appert, H Ye, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2016
Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)A S Cottereau, S Becker, F Broussais, et al.
Leukemia|November 28, 2014
KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotypeA Clipson, M Wang, L de Leval, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomesC Laurent, A Delas, P Gaulard, et al.
Blood Advances|August 4, 2025
Brentuximab Vedotin addition to Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphoma: a LYSA Phase II StudyOlivier Tournilhac, Krimo Bouabdallah, Solene Lecolant, et al.
Blood|December 2, 2025
Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP studyAndrew L Feldman, Surendra Dasari, Lisa M Rimsza, et al.
ESMO Open|January 5, 2021
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near futureP Hofman, M Ilié, E Chamorey, et al.
ESMO Open|September 15, 2023
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across EuropeP Hofman, F Calabrese, I Kern, et al.
Pageof 6